168 related articles for article (PubMed ID: 9681528)
1. Markers of cell proliferation in normal epithelia and dysplastic leukoplakias of the oral cavity.
Liu SC; Sauter ER; Clapper ML; Feldman RS; Levin L; Chen SY; Yen TJ; Ross E; Engstrom PF; Klein-Szanto AJ
Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):597-603. PubMed ID: 9681528
[TBL] [Abstract][Full Text] [Related]
2. Image analysis of p53 and cyclin D1 expression in premalignant lesions of the oral mucosa.
Liu SC; Hu Y; Sauter ER; Clapper ML; Chen SY; Lanfranchi HE; Engstrom PF; Klein-Szanto AJ
Anal Quant Cytol Histol; 1999 Apr; 21(2):166-73. PubMed ID: 10560487
[TBL] [Abstract][Full Text] [Related]
3. Markers of proliferation in normal and leukoplakic oral epithelia.
Liu SC; Klein-Szanto AJ
Oral Oncol; 2000 Mar; 36(2):145-51. PubMed ID: 10745166
[TBL] [Abstract][Full Text] [Related]
4. Predicting recurrence after oral precancer treatment: use of cell cycle analysis.
Thomson PJ; Hamadah O; Goodson ML; Cragg N; Booth C
Br J Oral Maxillofac Surg; 2008 Jul; 46(5):370-5. PubMed ID: 18282643
[TBL] [Abstract][Full Text] [Related]
5. Expression of granulocyte colony-stimulating factor receptor and platelet-derived endothelial cell growth factor in oral and oropharyngeal precancerous lesions.
Sunaga H; Fujieda S; Tsuzuki H; Asamoto K; Fukuda M; Saito H
Anticancer Res; 2001; 21(4B):2901-6. PubMed ID: 11712784
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic significance of cyclin D1, p27 and p63 expression in oral leukoplakia].
Kövesi G; Szende B
Magy Onkol; 2004; 48(4):309-13. PubMed ID: 15655576
[TBL] [Abstract][Full Text] [Related]
7. Proliferation of epithelia of noninvolved mucosa in patients with head and neck cancer.
Kotelnikov VM; Coon JS; Taylor S; Hutchinson J; Panje W; Caldareill DD; LaFollette S; Preisler HD
Head Neck; 1996; 18(6):522-8. PubMed ID: 8902565
[TBL] [Abstract][Full Text] [Related]
8. Biologic characteristics of esophageal epithelial dysplasia assessed by proliferating cell nuclear antigen.
Koga Y; Kuwano H; Sugimachi K
Cancer; 1996 Jan; 77(2):237-44. PubMed ID: 8625229
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of cyclin D1, p27, and p63 in oral leukoplakia.
Kövesi G; Szende B
J Oral Pathol Med; 2006 May; 35(5):274-7. PubMed ID: 16630290
[TBL] [Abstract][Full Text] [Related]
10. Minichromosome maintenance-7 and geminin are reliable prognostic markers in patients with oral squamous cell carcinoma: immunohistochemical study.
Tamura T; Shomori K; Haruki T; Nosaka K; Hamamoto Y; Shiomi T; Ryoke K; Ito H
J Oral Pathol Med; 2010 Apr; 39(4):328-34. PubMed ID: 20136698
[TBL] [Abstract][Full Text] [Related]
11. Expression of p27 and apoptosis in oral leukoplakia.
Tsuzuki H; Fujieda S; Sunaga H; Narita N; Tokuriki M; Saito H
Anticancer Res; 2003; 23(2B):1265-70. PubMed ID: 12820381
[TBL] [Abstract][Full Text] [Related]
12. Quantitative assessment of expression of cell adhesion molecule (CD44) splice variants: CD44 standard (CD44s) and v5, v6 isoforms in oral leukoplakias: an immunohistochemical study.
Godge PY; Poonja LS
Indian J Dent Res; 2011; 22(3):493-4. PubMed ID: 22048598
[TBL] [Abstract][Full Text] [Related]
13. A qualitative and quantitative estimation of AgNORS in dysplastic and non-dysplastic leukoplakias.
Pandit S; Aithal D
Indian J Dent Res; 2002; 13(1):27-30. PubMed ID: 12420565
[TBL] [Abstract][Full Text] [Related]
14. Characterization of epithelial cell activity in patients with oral cancer.
Thomson PJ; Potten CS; Appleton DR
Br J Oral Maxillofac Surg; 1999 Oct; 37(5):384-90. PubMed ID: 10577753
[TBL] [Abstract][Full Text] [Related]
15. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic significance of cyclin A expression in low-grade astrocytomas: comparison with astrogliosis and high-grade tumours.
Hara A; Saegusa M; Ichinoe M; Okayasu I
J Clin Pathol; 2008 Mar; 61(3):287-92. PubMed ID: 18156430
[TBL] [Abstract][Full Text] [Related]
17. Telomerase activity in premalignant and malignant lesions of human oral mucosa.
Kannan S; Tahara H; Yokozaki H; Mathew B; Nalinakumari KR; Nair MK; Tahara E
Cancer Epidemiol Biomarkers Prev; 1997 Jun; 6(6):413-20. PubMed ID: 9184774
[TBL] [Abstract][Full Text] [Related]
18. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
Rodins K; Cheale M; Coleman N; Fox SB
Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116
[TBL] [Abstract][Full Text] [Related]
19. Proliferating cell nuclear antigen (PCNA) as a marker of dysplasia in oral mucosa.
Martínez-Lara I; González-Moles MA; Ruiz-Avila I; Bravo M; Ramos MC; Fernández-Martínez JA
Acta Stomatol Belg; 1996 Mar; 93(1):29-32. PubMed ID: 8986050
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical assessment of Viadent-associated leukoplakia.
Anderson KM; Stoner GD; Fields HW; Chacon GE; Dohar AL; Gregg BR; Mallery SR
Oral Oncol; 2005 Feb; 41(2):200-7. PubMed ID: 15695122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
